Y.S.P. SOUTHEAST ASIA HOLDING |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.47 MYR | -0.40% |
|
+2.49% | +7.39% |
| Sales 2022 | 334M 70.07M 5.85B | Sales 2023 | 355M 74.42M 6.21B | Capitalization | 326M 68.39M 5.71B |
|---|---|---|---|---|---|
| Net income 2022 | 34M 7.13M 595M | Net income 2023 | 37M 7.76M 647M | EV / Sales 2022 | 0.77 x |
| Net cash position 2022 | 103M 21.62M 1.8B | Net cash position 2023 | 77.97M 16.35M 1.36B | EV / Sales 2023 | 0.7 x |
| P/E ratio 2022 |
10.4
x | P/E ratio 2023 |
8.73
x | Employees | - |
| Yield 2022 |
2.94% | Yield 2023 |
3.48% | Free-Float | 33.72% |
More Fundamentals
* Assessed data
More news
| 1 day | -0.40% | ||
| 1 week | +2.49% | ||
| Current month | +0.82% | ||
| 1 month | +0.82% | ||
| 3 months | +4.22% | ||
| 6 months | -1.20% | ||
| Current year | +7.39% |
1 week
2.40
2.49
1 month
2.402.49
Current year
2.292.49
1 year
2.262.61
3 years
1.882.92
5 years
1.453.05
10 years
1.193.49
| Managers | Title | Age | Since |
|---|---|---|---|
Fang Hsin Lee
CEO | Chief Executive Officer | 64 | 17/03/17 |
Siew Wai Yap
SAM | Sales & Marketing | 54 | 01/97/01 |
Mei Kee Kong
SEC | Corporate Secretary | - | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Ling Chin Lee
BRD | Director/Board Member | 75 | 16/05/16 |
Fang Hsin Lee
CEO | Chief Executive Officer | 64 | 17/03/17 |
Anis bin Ahmad
CHM | Chairman | 78 | 16/02/16 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 30/24/30 | 2.47 | -0.40% | 72,200 |
| 29/24/29 | 2.48 | +0.40% | 44,100 |
| 26/24/26 | 2.47 | -.--% | 21,700 |
| 25/24/25 | 2.47 | -.--% | 7,500 |
| 24/24/24 | 2.47 | +0.82% | 28,600 |
End-of-day quote BURSA MALAYSIA, April 30, 2024
More quotes
Y.S.P. Southeast Asia Holding Berhad is a Malaysia-based pharmaceutical company. The Company provides a range of pharmaceutical, over-the-counter (OTC), veterinary and aquatic products. The Company's segments include Manufacturing, Trading and Investment holding. The Manufacturing segment is engaged in the manufacturing of pharmaceutical products. The Trading segment is involved in the import, export and trading of various kinds of pharmaceutical, traditional herbal and veterinary products. The Company is engaged in investment holding and provision of management services. Its subsidiaries include Y.S.P. (Cambodia) Pte. Ltd., which provides management services in respect of product registration, trademark registration and national marketing and trading in all kinds of pharmaceutical products, and Alpha Active Industries Sdn. Bhd., which is engaged in the manufacturing of biotechnology products and health products.
Sector
Pharmaceuticals
Calendar
21/05/2024
- Q1 2024 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| +7.39% | 73.48M | |
| +19.27% | 43.18B | |
| +21.33% | 23.23B | |
| +15.11% | 14.6B | |
| +38.36% | 11.5B | |
| -7.77% | 6.79B | |
| -0.05% | 6.79B | |
| -8.87% | 5.73B | |
| +10.21% | 5.31B | |
| -2.27% | 4.81B |
- Stock Market
- Equities
- YSPSAH Stock
